Health Care's Epic Rallytalkmarkets.comAs the Tech/AI trade has hit a speed bump this month, the Health Care sector has been shot out of a cannon.
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Resultsfool.comOne clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.
ULTA Is No Longer A Cheap Stocktalkmarkets.comULTA is the leading player in a growing industry.
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crashfool.comA brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.
2 Unstoppable Growth Stocks I'd Buy Nowfool.comBoth of these electric air taxi pioneers have sold off hard recently, creating a potential entry point for patient investors.
Russell 2000 Earnings Dashboard 25Q3 - Thursday, Nov. 27talkmarkets.comThe 25Q3 Y/Y blended earnings growth estimate is 59.8%. If the energy sector is excluded, the growth rate for the index is 55.2%.
